SCHLAFLY V. THE SAINT LOUIS BREWERY, LLC
Contributed by Knobbe Martens. Originally published on Patexia; republished here as part of the LexDana archive.
Summary: Words that are primarily a surname can be registered as trademarks if they have acquired secondary meaning, even if the public also associates the surname with a famous individual.
The Saint Louis Brewery (“SLB”) was founded by Thomas Schlafly and began selling beer under the trademark SCHLAFLY in 1991. In 2011, SLB applied to register the mark SCHLAFLY for beer. A well-known individual with the same last name and a doctor who used the name Schlafly in his medical practice opposed (“the Opposers”). The Opposers argued the mark will have a negative connotation due to an association with drinking. The Board denied the opposition because the mark had acquired secondary meaning. The Board relied on the continuous use of the mark for more than 25 years, large sales volume, prominent mark placement, and more. The Opposers appealed.
The Federal Circuit affirmed. The Opposers argued the Lanham Act prohibits registration of marks that were “primarily merely a surname.” The Federal Circuit held that words that are primarily a surname can be registered trademarks if they have acquired secondary meaning. The Federal Circuit discussed typical evidence of secondary meaning, including 1) ownership of prior registrations, 2) five years of substantially exclusive and continuous use in commerce, and 3) other evidence, such as advertising expenditures. Because SLB presented all three types of evidence and more, the Board did not err in concluding that the mark SCHLAFLY for beers had acquired secondary meaning. Thus, the Federal Circuit affirmed.
More insights
Federal Circuit Affirms Invalidation of Patent for Lack of Enablement of Claims Directed to a Method of Treating a Patient with a Unit Dosage in Wyeth Llc v Astrazeneca Pharmaceuticals Lp
Written by : Eric Furman, Ph.D. and Ashley C. Morales Key Takeaway: Federal Circuit invalidates patent claims directed to a method for treating non-small cell lung cancer through administration of “a unit dosage” of an irreversible epidermal…
When About Becomes Indefinite Federal Circuit Provides Guidance for Life Science Patent Applications Regarding Limits of Approximation in Enviro Tech v Safe Foods
Written by : Jason J. Jardine and Kenneth O. Aruda, Ph.D. Key Takeaway: The term “about” remains useful in biotech and pharmaceutical claims, but only if the patent provides objective guidance about what the term means. Absent that guidance,…
When Any Patent Means No Patent Federal Circuit Reverses Non Specific Verdict
Written by : Brian C. Barnes and Sophia F. Zahn OLLNOVA TECHNOLOGIES LTD. v. ECOBEE TECHNOLOGIES ULC [OPINION] Before Chen , Cunningham, and Stark. Appeal from the United States District Court for the Eastern District of Texas. Summary : A verdict form…